MODIFICATION TO THE EMIT II PLUS COCAINE METABOLITE ASSAY— 510(k) K011162

Name: FDA 510(k) clearance K011162
Creator: U.S. Food and Drug Administration
Published: 2001-05-02

Substantially Equivalent

Syva Co., Dade Behring, Inc.

FDA 510(k) clearance K011162 for MODIFICATION TO THE EMIT II PLUS COCAINE METABOLITE ASSAY, Substantially Equivalent on 2001-05-02. Applicant: Syva Co., Dade Behring, Inc.. Device class: 2.

Clearance details

Applicant: Syva Co., Dade Behring, Inc.
Product code: Code DIO
Device class: Class 2
Regulation: 21 CFR 862.3250
Advisory panel: Clinical Toxicology
Date received: 2001-04-16
Decision date: 2001-05-02
Decision: Substantially Equivalent
Clearance type: Special
Location: San Jose, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DIO

view all

K213211 — Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM) Test System2022-01-27
K211973 — DRI Cocaine Metabolite Assay2021-09-24
K191638 — Pointe Scientific Cocaine Metabolite Enzyme Immunoassay2020-03-12
K181499 — DRI Cocaine Metabolite Assay2018-07-06
K170293 — Emit II Plus Cocaine Metabolite Assay2017-10-25

More clearances from Syva Co., Dade Behring, Inc.

view all

K011920 — EMIT 2000 DIGOXIN ASSAY, MODEL OSR4H2292001-07-02
K011620 — EMIT 2000 N-ACETYLPROCAINAMIDE ASSAY, MODEL OSR4N2292001-06-18
K011605 — EMIT 2000 QUINIDINE ASSAY, MODEL OSR4Q2292001-06-12
K011300 — EMIT II PLUS CANNABINOID ASSAY, MODEL OSR9N2292001-05-17
K011306 — EMIT II PLUS BENZODIAZEPINE ASSAY, MODEL 0SR9F2292001-05-16

Data sourced from openFDA. This site is unofficial and independent of the FDA.